• Study on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid

    Not recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Spain

  • Study of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson’s Disease

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany Poland

  • Study on the Safety and Effectiveness of Paltusotine for Patients with Acromegaly

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Hungary Italy Poland

  • Study Comparing Rituximab with Ibrutinib to Rituximab with Chemotherapy for Older Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Finland Norway Sweden

  • Study on Venetoclax, Ibrutinib, and Obinutuzumab for Chronic Lymphocytic Leukemia Patients Not in Complete Remission or with Detectable Bone Marrow Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark The Netherlands

  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Poland Sweden

  • Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Poland Spain +1

  • Study of Patritumab Deruxtecan for Patients with Previously Treated Metastatic or Locally Advanced EGFR-Mutated Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain

powered by